Comparing the efficacy and side-effects of PDLASTA® (Pegfilgrastim) with PDGRASTIM® (Filgrastim) in breast cancer patients: a non-inferiority randomized clinical trial

BACKGROUND: The objective of this study was to compare the efficacy and side effects of a single dose (Pegfilgrastim or PDL) or repeated six daily injections (Filgrastim or PDG) during chemotherapy courses in breast cancer patients in a non-inferiority clinical trial. METHODS: In this randomized cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Najafi, Safa, Ansari, Maryam, Kaveh, Vahid, Haghighat, Shahpar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066442/
https://www.ncbi.nlm.nih.gov/pubmed/33892670
http://dx.doi.org/10.1186/s12885-021-08197-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066442/
https://www.ncbi.nlm.nih.gov/pubmed/33892670
http://dx.doi.org/10.1186/s12885-021-08197-6

Ejemplares similares